Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 4Gastrointestinal 4Genitourinary 3Other solid neoplasm 2Thoracic 1Plasma cell 1Other 1Myeloid 1CNS 1Breast 1

Conditions

Motor Activity 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dosage Forms × Thoracic × Clear all
NCT07216209 2026-04-21

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

University of Arizona

Phase NA Recruiting
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡